KFF examines insulin cost-sharing caps for people with private insurance
The Kaiser Family Foundation released a policy brief examining cost-sharing caps for insulin among people with private insurance coverage. According to KFF, nearly 29 million American adults have been diagnosed with diabetes, and about one-third of them use insulin to manage the condition.
KFF noted that high insulin costs have kept many Americans from getting the medication they need. A monthly cap on what patients pay out-of-pocket is one approach being considered to make insulin more affordable, though such caps do not lower the actual price of insulin itself.
People with Medicare have had a $35 monthly cap on insulin costs since 2023, according to KFF. A 2024 KFF poll found that three-quarters of American adults support expanding this cap to people with other types of insurance, including employer plans. Support crossed party lines, with 84% of Democrats and 70% of Republicans favoring the expansion.
The KFF brief examines how cost-sharing caps work in existing state laws and proposed federal legislation, and considers key policy questions about whether this approach could improve insulin affordability for consumers with private coverage.
What it means in Raleigh
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.
